EA201200443A1 - COMBINED MEDICINE AND METHOD FOR TREATING VENOUS CEREBRAL DISCRIRCULATION - Google Patents
COMBINED MEDICINE AND METHOD FOR TREATING VENOUS CEREBRAL DISCRIRCULATIONInfo
- Publication number
- EA201200443A1 EA201200443A1 EA201200443A EA201200443A EA201200443A1 EA 201200443 A1 EA201200443 A1 EA 201200443A1 EA 201200443 A EA201200443 A EA 201200443A EA 201200443 A EA201200443 A EA 201200443A EA 201200443 A1 EA201200443 A1 EA 201200443A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- cerebral
- effective amount
- venous
- discrirculation
- discirculations
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Настоящее изобретение относится к комбинированному лекарственному средству для лечения венозных церебральных дисциркуляций, включающему терапевтически эффективное количество венозного ангиопротектора троксерутина и терапевтически эффективное количество церебрального ангиопротектора винпоцетина, а также к способу лечения венозных церебральных дисциркуляций, включающему введения указанного лекарственного средства. Настоящее изобретение также относится к способу лечения венозных церебральных дисциркуляций, включающему комбинированное введение эффективного количества троксерутина и эффективного количества винпоцетина. Комбинированное применение троксерутина и винпоцетина значительно снижает выраженность объективной и субъективной неврологической симптоматики при венозных церебральных дисциркуляциях.The present invention relates to a combination drug for the treatment of venous cerebral discirculations, including a therapeutically effective amount of the venous angioprotector troxerutin and a therapeutically effective amount of the cerebral angioprotector vinpocetine, as well as a method for treating venous cerebral discirculations including the administration of said drug. The present invention also relates to a method for treating venous cerebral discirculations, including the combined administration of an effective amount of troxerutin and an effective amount of vinpocetine. The combined use of troxerutin and vinpocetine significantly reduces the severity of objective and subjective neurological symptoms in venous cerebral dyscirculations.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201200443A EA201200443A1 (en) | 2012-03-14 | 2012-03-14 | COMBINED MEDICINE AND METHOD FOR TREATING VENOUS CEREBRAL DISCRIRCULATION |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EA201200443A EA201200443A1 (en) | 2012-03-14 | 2012-03-14 | COMBINED MEDICINE AND METHOD FOR TREATING VENOUS CEREBRAL DISCRIRCULATION |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201200443A1 true EA201200443A1 (en) | 2013-09-30 |
Family
ID=49232843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201200443A EA201200443A1 (en) | 2012-03-14 | 2012-03-14 | COMBINED MEDICINE AND METHOD FOR TREATING VENOUS CEREBRAL DISCRIRCULATION |
Country Status (1)
Country | Link |
---|---|
EA (1) | EA201200443A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2710716C1 (en) * | 2018-10-25 | 2020-01-10 | Василий Олегович Генералов | Method of producing angioprotective and nootropic agents |
-
2012
- 2012-03-14 EA EA201200443A patent/EA201200443A1/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2710716C1 (en) * | 2018-10-25 | 2020-01-10 | Василий Олегович Генералов | Method of producing angioprotective and nootropic agents |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12014502449A1 (en) | Methods for the treatment of diabetic retinopathy and other ophthalmic diseases | |
RU2018145985A (en) | ACTIVIN-ACTRII ANTAGONISTS AND THEIR APPLICATION FOR TREATMENT OF BONE TISSUE DISORDERS AND OTHER DISORDERS | |
EA201590655A8 (en) | COMBINATION OF LACHINIMODE AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
NZ704247A (en) | Compositions and treatment for eye diseases and disorders | |
EA201590654A1 (en) | COMBINATION OF RASAGILIN AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS, IN PARTICULAR OF HANTINGTON'S DISEASE | |
PH12014501997A1 (en) | Esketamine for the treatment of treatment-refractory or treatment-resistant depression | |
EA201891833A1 (en) | COMBINATION FOR THE TREATMENT OF AMIOTROPHIC SIDE SCLEROSIS OR RELATED DISEASES | |
NZ716627A (en) | Methods of treating behavioral symptoms of neurological and mental disorders | |
EA201690212A8 (en) | METHODS OF TREATMENT OR PREVENTION OF OPHTHALMIC PATHOLOGICAL CONDITIONS | |
BR112015022197A2 (en) | cataplexy treatment | |
EA201490746A2 (en) | APPLICATION OF PROGESTERON IN PREVENTION AND AFTER A ACUTE PERIOD TO IMPROVE THE OUTCOMES ASSOCIATED WITH THE CONVERGENCE OF THE BRAIN | |
EA201390060A1 (en) | ANNELED PYRIMIDINES AND TRIAZINES AND THEIR APPLICATION FOR THE TREATMENT AND / OR PREVENTION OF CARDIOVASCULAR DISEASES | |
UA109991C2 (en) | CARBAMATE COMPOUNDS, THEIR PREPARATION AND APPLICATION | |
IN2015DN00450A (en) | ||
BR112013029713A2 (en) | vision disorder treatment method | |
WO2015085143A3 (en) | Therapeutic agents for skin diseases and conditions | |
UY33206A (en) | METHODS OF TREATMENT OF AUTOIMMUNE DISEASES WITH DLL4 ANTAGONISTS | |
EA201400002A1 (en) | METHODS TO TREAT DISEASES OF THE RETAIL | |
EA201490721A1 (en) | Drug for the treatment of diseases of the anterior chamber of the eye, including rebamipid and tear-retaining agent | |
EA201590883A1 (en) | TREATMENT OF CANCER POMALIDOMIDE IN THE SUBJECT WITH RENAL FAILURE | |
EA201492102A1 (en) | ANTAGONISTS LINGO-2 FOR THE TREATMENT OF DISEASES IN WHICH MOTOR NEURONS PARTICIPATE | |
EA201691567A1 (en) | METHODS OF TREATING PULMONARY INJURIES TO THE BRAIN | |
WO2014153385A3 (en) | Methods of treating metabolic disorders | |
EA201591507A1 (en) | TREATMENT OF MULTIPLE SCLEROSIS BY LACHINIMODOM | |
MA32416B1 (en) | SUBSTITUTED 7-SULFANYLMETHYL-, 7-SULFINYMETHYL-AND 7-SULFONYLMETHYL-INDOLES AND THEIR USE |